SEPSF (ASEP Medical Holdings) Debt-to-Asset : 0.03 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SEPSF ASEP Medical Holdings Inc SEPSF
16 GF Score
Price $0.01
! 4 Warning Signs
View Full Analysis

What is ASEP Medical Holdings Debt-to-Asset?

ASEP Medical Holdings SEPSF 16 Debt-to-Asset is 0.03 as of Mar. 2026. GuruFocus rates SEPSF with a GF Score™ of 16/100. The stock has 4 warning signs investors should review.

ASEP Medical Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2026 was $0.02 Mil. ASEP Medical Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2026 was $0.17 Mil. ASEP Medical Holdings's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Mar. 2026 was $6.31 Mil. ASEP Medical Holdings's debt to asset for the quarter that ended in Mar. 2026 was 0.03.

ASEP Medical Holdings  (OTCPK:SEPSF) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

ASEP Medical Holdings Debt-to-Asset Related Terms

ASEP Medical Holdings Debt-to-Asset Historical Data

* Premium members only.

The historical data trend for ASEP Medical Holdings's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ASEP Medical Holdings Debt-to-Asset Chart

ASEP Medical Holdings Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Debt-to-Asset
0.00 0.00 0.00 0.00 0.03

ASEP Medical Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.02 0.02 0.03 0.03

SEPSF vs VRTX, REGN, MRNA: Debt-to-Asset Comparison

For the Biotechnology subindustry, ASEP Medical Holdings's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ASEP Medical Holdings Debt-to-Asset vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ASEP Medical Holdings's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where ASEP Medical Holdings's Debt-to-Asset falls into.


SEPSF
16GF Score
ASEP Medical Holdings Inc SEPSF
Debt-to-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ASEP Medical Holdings Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

ASEP Medical Holdings's Debt-to-Asset for the fiscal year that ended in Dec. 2025 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(0.018 + 0.162) / 6.319
=0.03

ASEP Medical Holdings's Debt-to-Asset for the quarter that ended in Mar. 2026 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(0.019 + 0.168) / 6.306
=0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Asset →
What does a Debt-to-Asset of 0.03 mean?
ASEP Medical Holdings (SEPSF) has a Debt-to-Asset of 0.03 as of Mar. 2026. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on ASEP Medical Holdings and its competitors.
Is ASEP Medical Holdings' Debt-to-Asset too high?
ASEP Medical Holdings' current Debt-to-Asset is 0.03. Overall, ASEP Medical Holdings has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does ASEP Medical Holdings' Debt-to-Asset compare to VRTX and REGN?
ASEP Medical Holdings' Debt-to-Asset of 0.03 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Asset for a Biotechnology company?
A good Debt-to-Asset depends on the Biotechnology industry context. However, Debt-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Asset mean?
A high Debt-to-Asset can signal that a stock is expensive relative to its fundamentals. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on ASEP Medical Holdings and its competitors. ASEP Medical Holdings's current Debt-to-Asset is 0.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ASEP Medical Holdings stock overvalued right now?
ASEP Medical Holdings (SEPSF) has a current Debt-to-Asset of 0.03. The current Debt-to-Asset is 0.03. ASEP Medical Holdings' overall GF Score™ is 16/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Asset calculated?
Debt-to-Asset is calculated from a company's financial statements. For ASEP Medical Holdings (SEPSF), the current Debt-to-Asset is 0.03 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ASEP Medical Holdings Business Description

Other Exchanges JJ80:GermanyASEP:Canada
Address 4400 Chatterton Way, Unit 202, Victoria, BC, CAN, V8X 5J2
ASEP Medical Holdings Inc is in the business of acquiring research and development assets, technologies and/or businesses in the area of life sciences and medical diagnostics. Diagnostic and therapeutic solutions represent tremendous clinical and commercial potential, through rapid diagnostics and uniquely effective treatments. Its Diagnostic has developed a novel diagnostic assay for the early and rapid risk assessment of sepsis. Therapeutic offering: Patented peptide technology targets infection-causing biofilms and reduces inflammation.
16GF Score

Get the complete analysis for SEPSF

Debt-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.01
Price